Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Moderna to complete US mRNA manufacturing network with $140 million investment - 2Don't miss the waxing moon swing by the Beehive star cluster March 27
- 310 Moving Design Frill for Summer 2023
- 4Horses really can smell our fear, new study finds
- 5New movies to watch this weekend: See 'They Will Kill You' in theaters, rent 'Send Help,' stream 'Pretty Lethal' on Prime Video
- Which Countries Would Suffer Most in a Global Energy Shutdown? This Study Has Answers
- What to know about the "wild, wild West" of viral peptide claims
- Most loved Occasion Dish: What Makes Your Merry Table?
- Doomed SpaceX Starlink satellite photographed from orbit
- FDA approves Wegovy pill for weight loss: What to know
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- Farmers call for French blockades over cow disease cull
- 5 Great Crossover Vehicles For Eco-friendliness In 2024
